Paul Reider
Corporate Officer/Principal at COHERUS BIOSCIENCES, INC.
Net worth: 156 865 $ as of 2024-04-29
Network origin in Paul Reider first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 30 | |
| Public Company | Pharmaceuticals: Major | 9 | |
| Subsidiary | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Paul Reider via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
| University of California, Davis | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
| HERON THERAPEUTICS, INC. | Biotechnology | General Counsel Chairman Director/Board Member | |
| TRISALUS LIFE SCIENCES, INC. | Medical Specialties | Chairman Chief Executive Officer | |
| RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| Tuck School of Business at Dartmouth | College/University | Masters Business Admin Masters Business Admin | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Founder Director/Board Member | |
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| COMERA LIFE SCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Founder | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ODONATE, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ZOSANO PHARMA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| University of California | College/University | Doctorate Degree Undergraduate Degree | |
| Neuvogen, Inc. | Director/Board Member Director/Board Member | ||
| HUMANIGEN, INC. | Biotechnology | Chairman Director/Board Member | |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Graduate Degree Doctorate Degree | |
| 21ST CENTURY ONCOLOGY HOLDINGS INC | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| Parenteral Drug Association | Chairman Corporate Officer/Principal | ||
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin | |
| PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member General Counsel | |
| PDL BIOPHARMA, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
GenesisCare USA, Inc.
 GenesisCare USA, Inc. Medical/Nursing ServicesHealth Services GenesisCare USA, Inc. provides radiation therapy services. It offers integrated cancer care, pulmonology, dermatology and radiation oncology. The company was founded in 1983 and is headquartered in Fort Myers, FL. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| DIADEXUS, INC. | Biotechnology | Director of Finance/CFO | |
Zimmer, Inc.
 Zimmer, Inc. Medical SpecialtiesHealth Technology Zimmer, Inc. provides joint replacement solutions. The firm products include trauma and dental implants and orthopaedic surgical products. The company was founded in 1927 and is headquartered in Warsaw, IN. | Medical Specialties | Corporate Officer/Principal | |
| Surgitek, Inc. | Corporate Officer/Principal | ||
JBL Scientific, Inc.
 JBL Scientific, Inc. Chemicals: Major DiversifiedProcess Industries Part of Promega Corp., JBL Scientific, Inc. is an American company that makes specialty chemical products. JBL Scientific was acquired by Promega Corp. from Genta, Inc. on May 11, 1999. | Chemicals: Major Diversified | Corporate Officer/Principal | |
San Francisco State University Foundation, Inc. (California)
 San Francisco State University Foundation, Inc. (California) Investment Trusts/Mutual FundsMiscellaneous San Francisco State University Foundation, Inc. engages in the provision of philanthropic services. It raises private funds to support the university. The company was founded in 1899 and is headquartered in San Francisco, CA. | Investment Trusts/Mutual Funds | Director/Board Member | |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Keck Graduate Institute of Applied Life Sciences | College/University | Corporate Officer/Principal | |
Alphatec Spine, Inc.
 Alphatec Spine, Inc. Medical SpecialtiesHealth Technology Alphatec Spine, Inc. is focused on the design, development, manufacturing, and marketing of products for the surgical treatment of spine disorders, with a focus on treating condition affecting the aging spine. The firms product portfolio and pipeline include spinal disorder products and systems. The company was founded in 1990 and is headquartered in Carlsbad, CA. | Medical Specialties | Director of Finance/CFO | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Consensus Orthopedics, Inc.
 Consensus Orthopedics, Inc. Medical SpecialtiesHealth Technology Consensus Orthopedics, Inc. provides total joint implants and instruments. Its products include Consensus knee and hip and CS2 Acetabular Cup systems. The company was founded in July 1992 and is headquartered in El Dorado Hills, CA. | Medical Specialties | Director of Finance/CFO | |
| St. John's College | College/University | Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin | |
| St. Francis College | College/University | Masters Business Admin | |
| CORCEPT THERAPEUTICS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Graduate Degree | |
| Drexel University | College/University | Undergraduate Degree |
Statistics
International
| United States | 51 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 16 |
| Health Services | 3 |
| Process Industries | 2 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 223 |
| Corporate Officer/Principal | 111 |
| Independent Dir/Board Member | 76 |
| Undergraduate Degree | 39 |
| Chief Executive Officer | 38 |
Most connected contacts
| Insiders | |
|---|---|
| James Healy | 50 |
| Alan C. Mendelson | 45 |
| Samuel R. Nussbaum | 32 |
| Mark Stolper | 28 |
| Ali Satvat | 28 |
| Mats Wahlström | 22 |
| V. Lawlis | 21 |
| Mary Szela | 19 |
| Kevin Tang | 18 |
| Georgia Erbez | 18 |
| Craig Johnson | 17 |
| Barbara Finck | 15 |
| Denny Lanfear | 13 |
| Jean-Frédéric Viret | 13 |
| Lee Newcomer | 13 |
- Stock Market
- Insiders
- Paul Reider
- Company connections
